跳至主要内容
临床试验/ISRCTN29686154
ISRCTN29686154已完成不适用

Prevention of catheter-related deep vein thrombosis with nadroparin in hemato-oncology patients treated with high dose chemotherapy

Academic Medical Center (AMC) (The Netherlands)0 个研究点目标入组 100 人开始时间: 2006年6月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Central venous catheter
  • 2. Indication for high dose chemotherapy (acute myeloid leukaemia [AML], acute lymphoblastic leukaemia [ALL], myelodysplasia-refractory anemia with excess of blasts in transformation [MDS-RAEB], multiple mye!oma [MM])
  • 3. Informed consent

排除标准

  • 1. Current anticoagulant therapy
  • 2. Allergy for contrastmedia
  • 3.Promyelocytic leukemia (AML-M3)
  • 4. Bleeding tendency
  • 5. Renal failure

研究者

发起方
Academic Medical Center (AMC) (The Netherlands)

相似试验

Prevention of catheter-related deep vein thrombosis... | 临床试验